Improve walking through Amazonian dance
- Trial ID
- NCT06967493
- Official Title
- "Amazonian Dance for Parkinson": a Protocol Study for a Randomized Clinical Trial on Motor and Non-motor Symptoms of People With Parkinson's.
- Goal
- Improve walking through Amazonian dance
- Phase
- NA
- Status
- RECRUITING
- Sponsor
- Federal University of Rio Grande do Sul
- Study Type
- INTERVENTIONAL
- Enrollment
- 80 participants
- Conditions
- Parkinson Disease
- Interventions
- Amazonian Dance, Nordic Walking
Summary For Families
Goal: to see if a guided Amazonian Dance program can improve walking, balance, mood and thinking in people with mild to moderate Parkinson's, compared with a structured aerobic option. Approach: participants are randomized to Amazonian Dance, which uses music, rhythmic stepping, coordinated limb patterns and cognitive challenges to retrain timing, balance and gait, or to Nordic walking, which uses poles to boost posture and aerobic fitness; both are offered as add-on physical therapies alongside regular anti-Parkinson medications and do not replace levodopa or other drugs. Eligibility: adults 50 to 80 years old with Parkinson's at Hoehn and Yahr stages I to III who have been on anti-Parkinson drugs for at least a year and can follow instructions; people with recent surgery, DBS, pacemakers, other neurologic or serious chronic diseases, or lower-limb prostheses are excluded.
Locations
- Universidade Federal do Pará, Castanhal, Pennsylvania, Brazil
- Universidade Federal do Rio Grande do Sul, Porto Alegre, Rio Grande do Sul, Brazil
Frequently Asked Questions
- What is this trial testing?
- This trial is studying Amazonian Dance. Goal: to see if a guided Amazonian Dance program can improve walking, balance, mood and thinking in people with mild to moderate Parkinson's, compared with a structured aerobic option. Approach: participants are randomized to Amazonian Dance, which uses music, rhythmic stepping, coordinated limb patterns and cognitive challenges to retrain timing, balance and gait, or to Nordic walking, which uses poles to boost posture and aerobic fitness; both are offered as add-on physical therapies alongside regular anti-Parkinson medications and do not replace levodopa or other drugs. Eligibility: adults 50 to 80 years old with Parkinson's at Hoehn and Yahr stages I to III who have been on anti-Parkinson drugs for at least a year and can follow instructions; people with recent surgery, DBS, pacemakers, other neurologic or serious chronic diseases, or lower-limb prostheses are excluded.
- Who can participate?
- Participants must be between 50 Years and 80 Years.
- Where is this trial located?
- This trial is recruiting at 2 locations.
- Does it cost anything to join?
- No. There is no cost to participate. Study-related care and treatment are provided at no charge.
- How long does the trial last?
- This trial is estimated to last approximately 4 months.
- Will I get the real drug or a placebo?
- It depends on the trial design. Some Parkinson's trials are placebo controlled, meaning a portion of participants get an inactive comparison while others get the experimental treatment. Some use crossover designs so everyone eventually receives the active treatment at some point. Observational trials do not use a placebo at all because they are not testing a new treatment. The consent form for any specific trial spells out the design and your odds of being assigned to placebo before you enroll.
- How often will I need to visit the study site?
- Visit frequency varies by trial. Many Parkinson's studies require an in person visit every 4 to 12 weeks during the active treatment phase, with shorter or longer gaps depending on the design. The site coordinator can give you the full visit schedule before you sign anything, so you know what the time commitment looks like.
- Can I leave the trial if I change my mind?
- Yes. You can withdraw from any clinical trial at any time, for any reason, without affecting your standard medical care. Trials are voluntary by law. The team may ask if you are willing to do a brief exit visit so they can collect safety information, but you are not obligated.
- Will travel or parking be reimbursed?
- Many trials reimburse for parking, mileage, and sometimes lodging if the site is far from your home. Reimbursement policies vary by sponsor and site. When you contact the trial team, ask specifically what is covered and how reimbursement is processed.
- Can my spouse or care partner come with me to visits?
- In most cases yes, and it is often encouraged. Care partners can help with notes, questions, and getting home safely after a long visit. Some study assessments do need to happen one on one, but care partners are usually welcome for the rest of the appointment.